FDA authorizes marketing of four Glas electronic nicotine delivery systems

The U.S. Food and Drug Administration authorized the marketing of four Glas electronic nicotine delivery systems through the premarket tobacco product application pathway. Each product is an e-liquid pod containing 50mg/ml, or 5%, of tobacco-derived nicotine. The authorized pods include Classic Menthol, Fresh Menthol, Gold, and Sapphire. This action marks the FDA’s first authorization of non-tobacco and non-menthol ENDS products. Publicly traded companies in the space include Altria Group (MO), British American Tobacco (BTI), Imperial Brands (IMBBY) and Philip Morris (PM).